Esters for Treatment of Ocular Inflammatory Conditions
Johnson & Johnson Vision Care, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/503,158, filed Jun 30, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,865,685 | Esters for Treatment of Ocular Inflammatory Conditions In force · High confidence | Johnson & Johnson Vision Care, Inc. | In force | High confidence | ||
| US 10,588,887 | Esters for Treatment of Ocular Inflammatory Conditions In force · Medium confidence | Johnson & Johnson Vision Care, Inc. | In force | Medium confidence | ||
| US 11,096,919 | Esters for Treatment of Ocular Inflammatory Conditions In force · Medium confidence | Johnson & Johnson Vision Care, Inc. | In force | Medium confidence | ||
| US 11,311,510 | Esters for Treatment of Ocular Inflammatory Conditions In force · Medium confidence | Johnson & Johnson Vision Care, Inc. | In force | Medium confidence | ||
| US 12,364,679 | Esters for Treatment of Ocular Inflammatory Conditions In force · Medium confidence | Johnson & Johnson Vision Care, Inc. | In force | Medium confidence | ||
| US 10,383,839 | Esters for Treatment of Ocular Inflammatory Conditions In force · High confidence | Johnson & Johnson Vision Care, Inc. | In force | High confidence | ||
| Application 16/831,011 | Esters for Treatment of Ocular Inflammatory Conditions Abandoned Abandoned Aug 11, 2023 | Johnson & Johnson Vision Care, Inc. | Abandoned | Abandoned Aug 11, 2023 |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Johnson & Johnson Vision Care, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.